Objectives-We aimed to determine the most efficient quantitative parameters to establish a contrast-enhanced ultrasound (US) assessment system for distinguishing between benign and malignant thyroid nodules.
the enhancement pattern, "ring enhancement" and "homogeneity" provide valuable indicators in the differential diagnosis of thyroid nodules. 2 Moreover, a hypoenhanced lesion is a sensitive, accurate predictor of a malignant thyroid nodule. Truly, this semiquantitative assessment method of contrast-enhanced US has high accuracy in differentiating thyroid nodules. 3 However, some researchers have noted that contrast-enhanced US has limited value in the assessment of thyroid nodules because the contrast-enhanced US interpretation procedure is highly dependent on the operators' experience and somewhat subjective. 4 The other reason comes from the overlapping enhancement between malignant and benign nodules under contrast-enhanced US. 5 Recently, quantitative analysis by contrast-enhanced US has come into use in the diagnosis of thyroid nodules. A series of quantitative parameters and a timeintensity curve of a region of interest (ROI) are used to estimate the microvascular density of nodules and provide information for clinical treatment. 6 The quantitative contrast-enhanced US parameters include the peak intensity, ascend slope, descend slope, area under the curve (AUC), time from peak to one-half, and time to peak. Both the peak intensity and time to peak are suggested to correlate with the histologic type of thyroid nodules. 7 The nodule-to-perinodule of time to peak ratio (<1.15) has been reported to be associated with thyroid malignancies. 8 In addition to the peak intensity and time to peak, the AUC has also been reported to be significantly different between benign and malignant perinodule tissues. 9 Compared to adjacent thyroid tissues, Argalia et al 10 pointed out that the wash-out curves were monophasic in 93% of benign lesions and polyphasic in 89% of malignant lesions. Moreover, researchers propose that malignant nodules are characterized as having slow fill-in and rapid wash-out. 11 Since quantitative analysis is helpful for discriminating suspicious thyroid lesions, 12, 13 in this study, we tried to establish an efficient diagnostic model for differentiating suspicious thyroid lesions by using these contrastenhanced US parameters.
Materials and Methods

Patients and Data Collection
From July to September in 2016, we collected 167 patients who had thyroid nodules and underwent thyroid examinations with conventional and contrastenhanced US in the Department of Ultrasound of the Third Xiangya Hospital. This study was approved by the Ethics Committee of the Third Xiangya Hospital of Central South University. Informed consent was obtained from each patient before the study. The histologic types of the thyroid nodules were confirmed by surgery or fine-needle aspiration. The inclusion criteria were as follows: (1) patients had solid or mainly solid thyroid nodules; and (2) the nodules had at least 1 of the suspicious features (solid component, hypoechogenicity or marked hypoechogenicity, irregular margins, microcalcifications, and a taller-than-wide shape) on US imaging. The exclusion criteria were as follows: (1) nodules were dominantly cystic; (2) patients were pregnant; and (3) suspicious thyroid nodules were eggshell calcified.
A total of 161 patients with 167 suspicious nodules were recruited. Information, such as patient age and sex, nodule size, laterality, US characteristics (echo, margin involvement, calcifications, and a taller-than-wide shape), and quantitative contrast-enhanced US indicators (ascend slope, descend slope, peak intensity, AUC, time from peak to one-half, and time to peak) in both nodule and perinodule areas were collected.
Conventional and Contrast-Enhanced US Performance
All of the US examinations were performed with commercially available scanners (DC-8EXP; Mindray, Shenzhen, China) equipped with an L12-3E transducer for both conventional and contrast-enhanced US with ultra-wideband nonlinear contrast imaging. The US focus was placed at the same level during the examination. We gathered the following information with conventional US: echo (hypo, iso, or hyper level), composition (solitary or mixed), taller-than-wide shape, nodule margin, and calcifications.
After conventional US, we switched the transducer to the contrast-enhanced US mode. To minimize microbubble destruction and artificial signal loss, contrast-enhanced US imaging was performed at low acoustic intensities (low mechanical index of 0.15). A sulfur hexafluoride microbubble contrast medium SonoVue (2.4 mL, BR1; Bracco SpA, Milan, Italy) bolus was injected intravenously, followed by injection of normal saline (5 mL). Each image acquisition lasted for 3 minutes after the bolus injection, and the imagies were stored automatically. If a patient had more than 2 suspicious nodules, another 2.4-mL SonoVue bolus was injected after 10 minutes. Images were quantitative analyzed with Contrast Imaging QA software. The ROI was set in the most evident enhanced region, and the same ROI area was copied in perinodule thyroid tissues and served as a control (Figure 1) . A time-intensity curve and all of the quantitative parameters were generated to show the contrast-enhanced US performance as follows: (1) peak intensity-hypoenhancement meant a lower nodule peak intensity than perinodule peak intensity, and hyperenhancement meant a higher nodule peak intensity than perinodule tissue; (2) ascend slope-compared to perinodule tissues, a lower nodule ascend slope meant slow wash-in, and a higher nodule ascend slope meant rapid wash-in; (3) descend slope (a negative number)-compared to perinodule tissues, a lower nodule descend slope meant rapid wash-out, and a higher nodule descend slope meant slow wash-out; (4) time to peak-compared to perinodule tissues, a lower nodule time to peak meant rapid wash-in, and a higher nodule time to peak meant slow wash-in; (5) time from peak to one-half-compared to perinodule tissues, a lower nodule time from peak to one-half meant slow washout, and a higher nodule time from peak to one-half meant rapid wash-out; and (6) AUC-compared to perinodule tissues, a lower nodule AUC meant a nodule vascular deficiency. Since the nodule values were always compared to perinodule values, the ratios of nodule and perinodule values were adopted to evaluate the thyroid nodules.
Ultrasound examinations was performed by a single experienced examiner, and the quantitative analysis of contrast-enhanced US was performed by trained sonographers. These sonographers were blinded to clinical data and other imaging findings.
Histologic Confirmation
All included patients underwent surgery or fine-needle aspiration. The histologic result was the reference diagnostic standard. A cytologic analysis was done according to the Bethesda classification system. 14 The benign group (n 5 70) included nodular goiters and follicular adenomas. The malignant group (n 5 97) included papillary thyroid carcinomas, medullary thyroid carcinomas, and undifferentiated carcinomas. 
Statistical Methods
The primary outcome measure was malignant thyroid nodules. The candidate indicators included age, sex, US parameters (tumor size, laterality, calcifications, solid composition, margin, echo, and taller-than-wide shape), and quantitative contrast-enhanced US parameters (ascend slope, descend slope, peak intensity, AUC, time from peak to one-half, and time to peak). Numeric variables were summarized as the mean 6 standard deviation or median (interquartile range) where appropriate. Categorical variables were reported as counts (percentages). Independent group proportions were compared by a v 2 test or Fisher exact test. Independent group means were compared by a Student t test or nonparametric Wilcoxon Mann-Whitney test. Odds ratios of malignant events for candidate risk indicators were determined by logistic regression modeling. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cutoffs that maximized sensitivity and specificity in predicting malignancies. All tests of hypotheses were 2 tailed and conducted at a significance level of P < .05. Statistical analyses were conducted with SAS version 9.4 software (SAS Institute Inc, Cary, NC).
Results
Demographic and US Features of the Thyroid Nodules
As shown in Table 1 , of 161 recruited patients with solid thyroid nodules, 43 were male and 118 were female. Sixty-eight nodules were benign, and 93 were malignant. The information about thyroid nodule size, position, laterality, and other characteristics is summarized in Table 1 . Among 93 malignant nodules, 78.49% had calcifications; 62.36% had an obscure boundary with spiculation; 87.10% were hypoechoic; and 27.96% had a taller-than-wide shape. Under conventional US, the perinodule thyroid tissues were normal. Histologic results of perinodule tissues were also confirmed by biopsy after surgery or fine-needle aspiration. A hypoechoic nodule meant that the nodule had a lower echo compared to perinodule tissues under conventional US. Based on the international accepted Thyroid Imaging Reporting and Data System (TI-RADS) classification, [14] [15] [16] 55, 22, 33, and 51 recruited nodules were in levels 3, 4a, 4b, and 5, respectively. TI-RADS 4a nodules were supposed to be benign. However, 63.64% of TI-RADS 4a nodules were malignant. Therefore, to optimize the US application in thyroid nodule diagnosis, we performed a quantitative analysis of the contrastenhanced US parameters. Under contrast-enhanced US, malignant nodules had significantly lower ascend slope, peak intensity, and AUC values and higher descend slope values compared to benign nodules (P < .0001; Table 2 ). For perinodule tissue, we also recorded their contrast-enhanced US parameter values (Table 2) .
Risk Effect of Time-Independent Contrast-Enhanced US Indicators As shown in Table 3 , young age and US features, including calcifications, margin involvement, echo, and a tallerthan-wide shape, were risk factors for malignant thyroid nodules. For contrast-enhanced US indicators, the quantitative parameters peak intensity, ascend slope, descend slope, and AUC in both nodule and perinodule tissues were significantly associated with malignancies. .06
Data are presented as mean 6 SD and median (interquartile range). Abbreviations in tables are as in Figure 1 .
However, the time to peak and time from peak to onehalf had no such association (P > .05). Table 3 shows that a higher nodule ascend slope, peak intensity, and AUC and a lower perinodule descend slope were protective factors (odds radio, < 1; P < .05), whereas a higher perinodule ascend slope, peak intensity, and AUC and a lower nodule descend slope were risk factors (odds ratio, > 1; P < .05).
When comparing the nodule parameters with perinodule parameters, we found that peak intensity, ascend slope, and AUC values were significantly higher in perinodule tissue than nodule tissue in malignant nodules (Figure 2, A-C) . In benign nodules, these values were higher in the nodule regions compared to perinodule regions. The descend slope was an exception. In nodule regions, the descend slope was higher in malignancies and lower in benign nodules ( Figure 2D ). Taken together, malignant nodules were characterized as having hypoenhancement, slow wash-in, rapid wash-out, and deficiency in nodule vascularity.
To further clarify the nodule/perinodule differences between malignant and benign nodules, the nodule-to-perinodule ratios of the time-independent indicators were compared between the groups of nodules. As shown in Figure 3 , A-C, the ratios of the ascend slope, descend slope, peak intensity, and AUC were all less than 1 in malignant nodules, whereas these ratios were all greater than 1 in benign nodules. The differences were significant for these quantitative parameters.
Diagnostic Efficiency of Quantitative ContrastEnhanced US Indicators
Since a low nodule ascend slope, peak intensity, and AUC and a high nodule descend slope were associated with malignant thyroid nodules, their diagnostic efficiencies were evaluated individually and jointly. Figure 2 . Nodule and perinodule value comparison between benign and malignant thyroid nodules for contrast-enhanced US parameters. PI indicates peak intensity, AS, ascend slope, DS, descend slope, AUC, area under the curve, TTP, time to peak, and DT/2, descend time to one-half.
The ROC curves for the nodule peak intensity, ascend slope, descend slope, and AUC in Figure 4 showed that the AUC values were 0.7583, 0.7250, 0.7508, and 0.7375, respectively. The optimal cutoff values for the nodule peak intensity, ascend slope, descend slope, and AUC were 20.75, 0.91, 20.2, and 1818.23. Their sensitivities and specificities are listed in online supplemental Tables 1-4 . As shown in supplemental Figure 1C , the nodule-to-perinodule peak intensity ratio was more efficient for diagnosis than the nodule value. The ROC contrast between the peak intensity ratio versus the nodule peak intensity value was significantly higher (ROC contrast, 0.0546; 95% confidence interval [CI], 0.0098, 0.0995; P 5 .02; supplemental Table 1) . Moreover, as shown in supplemental Figure 4C , the ROC contrast between the AUC ratio and nodule AUC was marginally higher (ROC contrast, 0.0547; 95% CI, 20.0095, 0.1189; P 5 .0948; supplemental Table 4 ). In a joint analysis, the combination of the nodule peak intensity, ascend slope, descend slope, and AUC had an AUC of 0.7694, which were significantly lower compared to the ratio combination, with an AUC of 0.8039 (Table 5) .
Ratio Cutoffs of Time-Independent Contrast-Enhanced US Indicators for Diagnosis
As shown in supplemental Tables 1-4 , the optimal ratio cutoffs were 0.90, 0.95, 0.96, and 0.96 for the peak intensity, ascend slope, descend slope, and AUC, respectively. In the joint model, we applied these cutoff values to convert continuous ratio variables into dichotomous variables. As shown in Figure  5 , even though the time to peak and time from peak to one-half were insignificantly associated with malignant thyroid nodules, they still contributed to the diagnostic efficiency. Compared to the joint ratio model with 4 time-independent contrast-enhanced US indicators, the joint ratio model with 6 indicators was more efficient in diagnosis (6-versus 4-ratio combination, P 5 .15; Table 4 ). Compared to the full model (nodule values plus 6 ratio values), the joint ratio model with 6 contrast-enhanced US indicators was sufficient enough (full model versus 6-ratio combination, P 5 .50; Table 4 ). The sensitivity and specificity are summarized in Table 5 . When comparing all of the included models, the nodule-to-perinodule peak intensity ratio contributed most to the final full models.
As for the diagnostic efficiency, we found that the AUC of nodule peak intensity, ascend slope, descend slope and AUC were 0.7730, 0.7285, 0.7564, and 0.7371, respectively (supplemental Figures 1-4) . The combination of nodule peak intensity, ascend slope, descend slope, and AUC values had an AUC of 0.7694 (Table 5) , which were significantly lower compared to the ratio combination, with an AUC of 0.8070 ( Table   Figure 3 . Comparison of the nodule-to-perinodule ratio between benign and malignant thyroid nodules for contrast-enhanced US parameters. PI indicates peak intensity, AS, ascend slope, DS, descend slope, AUC, area under the curve, TTP, time to peak, and DT/2, descend time to one-half. 5). Because the ratio index could eliminate the effect of the background of the thyroid gland and individual variations, the ratio model is more efficient.
Performance of TI-RADS Plus Contrast-Enhanced US Parameters
To evaluate the diagnostic value of contrast-enhanced US in suspected thyroid nodules, contrast-enhanced US parameters were added to the TI-RADS. As shown in Table 6 , the rate of malignancies in TI-RADS 4a nodules was 63.64%. Usually, TI-RADS 4a nodules were suspected to be benign, whereas TI-RADS 4b nodules were suspected to be malignant. However, the performance of the TI-RADS based on conventional US was unsatisfactory. Therefore, the contrast-enhanced US parameters were used to improve the TI-RADS classification. We used the contrast-enhanced US peak intensity, ascend slope, descend slope, and AUC nodule-toperinodule ratios and TI-RADS to construct a novel classification system. In this novel system, the rate of malignancy in TI-RADS 4a nodules decreased to 0%. The sensitivity and specificity of the novel classification system were 90.10% and 96.67%, respectively (Table 6 ).
Discussion
Endocrinologists often have difficulty differentiating benign and malignant thyroid nodules before surgery. Under conventional US, hypoechogenicity, including marked hypoechogenicity, has been suggested as a helpful criterion in the diagnosis of malignant nodules, with sensitivity of 87.2% and specificity of 58.5%. 17 In addition to conventional US, contrast-enhanced US, which represents a highly sensitive method for detecting the microvascularization of thyroid carcinomas, 18 is a feasible technique for characterizing thyroid nodules. In previous studies, researchers have demonstrated that, under contrast-enhanced US, ring enhancement indicates a benign lesion with accuracy of 88.5%, whereas heterogeneous enhancement suggests a malignant lesion with accuracy of 90.4%. 4 However, the overlapping of enhanced intensity between malignant and benign nodules might interfere with the contrast-enhanced US operator's judgment. Also, contrast-enhanced US operators sometimes could be somewhat subjective. To avoid these limitations, a contrast-enhanced US time-intensity curve was generated on the basis of the blood kinetic information of the thyroid nodules. Quantitative analysis of the time-intensity curve is a more effective method in thyroid nodule assessment.
However, the use of quantitative analysis in predicting malignant thyroid nodules is still controversial, and no consensus or formal guideline regarding the contrastenhanced US time-intensity curve for thyroid tumors has been published yet. In this study, we conducted a comprehensive quantitative analysis of the thyroid nodules' time-intensity curves. The parameters peak intensity, ascend slope, descend slope, and AUC were tightly correlated with the attribution of thyroid nodule microvessels. The microvessel density of malignant nodules is reported to be far behind that of benign nodules. 18 Therefore, in this study, we used quantitative parameters, including peak intensity, ascend slope, descend slope, AUC, time to peak, and time from peak to onehalf. There were significant differences between benign and malignant nodules in the peak intensity, ascend slope, descend slope, and AUC. However, the time to peak and time from peak to one-half had no significant differences between malignant and benign nodules. These results were partly consistent with a previous report, which suggested no differences in the rising time and time to peak among thyroid papillary carcinomas, nodular goiters, and follicular adenomas. 19 In this study, we demonstrated that a low nodule peak intensity and AUC were associated with malignant thyroid nodules (Table 2) , indicating the deficiency of vascularization of malignant lesions. These results are supported by a recent Doppler US report of vascularity absence in 60% of malignant nodules and 43% of benign nodules. 20 The optimal cutoffs of peak intensity and AUC nodule-to-perinodule ratio were 0.90 and 0.96, respectively (Table 5) , which provided a useful additional unified criterion for thyroid nodule classification under contrast-enhanced US and even effective information for treatment.
The peak intensity is generally recognized as the most sensitive index for differentiating thyroid nodules. 19 Our results showed a similar result (Table 5) . Furthermore, given that the ascending and descending branches of the time-intensity curve reflects the changes in microbubble velocity and flow capacity with time, 21 we paid 
